TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15824681

Group type: EXPERIMENTAL
Intervention: High-dose epinephrine (HDE) 0.1 mg/kg for initial dose and 0.2 mg/kg for subsequent doses
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: High-dose epinephrine (HDE)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Standard-dose epinephrine (SDE) 0.01 mg/kg
Number of subjects: 230

Group type: COMPARATOR
Intervention: Standard-dose epinephrine (SDE)
Number of subjects: 230
Study: 12473877

Group type: EXPERIMENTAL
Intervention: Pravastatin therapy
Number of subjects: 9014

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 9014
Study: 9830877

Group type: EXPERIMENTAL
Intervention: Social support intervention
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Education about appropriate use of the health care system
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Combination of social support and education
Number of subjects: 363

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 363
Study: 7990367

Group type: EXPERIMENTAL
Intervention: Microwave resonance treatment (MRT)
Number of subjects: 0
Study: 2660322

Group type: EXPERIMENTAL
Intervention: Continuous subcuticular resorbable suture
Number of subjects: 166

Group type: COMPARATOR
Intervention: Monofilament nylon mattress suture
Number of subjects: 166
Study: 28252881

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 40
Study: 27641426

Group type: EXPERIMENTAL
Intervention: Mediolateral episiotomy
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Lateral episiotomy
Number of subjects: 666
Study: 23952289

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 23027399

Group type: EXPERIMENTAL
Intervention: Fast dynamic stretching (FDS) of the gluteus maximus muscle
Number of subjects: 12
Study: 20453574

Group type: EXPERIMENTAL
Intervention: Breast-feeding education and support services
Number of subjects: 39

Group type: COMPARATOR
Intervention: Breast-feeding education only (control group)
Number of subjects: 39
Study: 20078015

Group type: EXPERIMENTAL
Intervention: Telehealth system during episode of care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine home visits only
Number of subjects: 0
Study: 16160626

Group type: EXPERIMENTAL
Intervention: Paroxetine (PAR) up to 40 mg daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR (VEN-XR) up to 225 mg daily
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 14672467

Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral training for urge incontinence (8 weeks, four visits)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral training for stress incontinence (8 weeks, four visits)
Number of subjects: 258
Study: 10539493

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 8857627

Group type: EXPERIMENTAL
Intervention: Inpatient programme (4 weeks)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Outpatient programme (8 half days per week)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 121
Study: 8314541

Group type: COMPARATOR
Intervention: Radiation alone
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Platinum-based chemotherapy and radiotherapy
Number of subjects: 35
Study: 3303886

Group type: EXPERIMENTAL
Intervention: Diltiazem (90 mg every 6 hours)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 576
Study: 31558624

Group type: EXPERIMENTAL
Intervention: 20 mg daily oral sustained-release morphine
Number of subjects: 284

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study: 29995672

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Histamine H2 receptor blockers (H2RBs)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No coadministration of gastric acid suppressants (Control group)
Number of subjects: 42
Study: 28025956

Group type: EXPERIMENTAL
Intervention: Community-based participatory nutrition promotion (CPNP) programme
Number of subjects: 1790

Group type: COMPARATOR
Intervention: Control group (government nutrition programme only)
Number of subjects: 1790
Study: 25867913

Group type: EXPERIMENTAL
Intervention: D/C/F/TAF (Tenofovir Alafenamide)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Darunavir + cobicistat + emtricitabine/tenofovir disoproxil fumarate (TDF)
Number of subjects: 153
Study: 23632800

Group type: EXPERIMENTAL
Intervention: Trocar‐guided transvaginal mesh insertion
Number of subjects: 79

Group type: COMPARATOR
Intervention: Anterior colporrhaphy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both interventions (mesh and colporrhaphy)
Number of subjects: 79
Study: 21763057

Group type: EXPERIMENTAL
Intervention: Bougie
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Stylet
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: McCoy laryngoscope
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Airtraq™
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask (ILMA)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Standard intubation
Number of subjects: 66
Study: 19576015

Group type: EXPERIMENTAL
Intervention: VEGF(165) cultured dendritic cells in vitro
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Serum VEGF in OSCC patients
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Peripheral blood DC in OSCC patients
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Expression of VEGF in primary foci
Number of subjects: 81
Study: 16784647

Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Arterial bypass
Number of subjects: 39
Study: 15109930

Group type: EXPERIMENTAL
Intervention: Maternal smoking (SM)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non‐smoking (NS)
Number of subjects: 24
Study: 11684139

Group type: EXPERIMENTAL
Intervention: Sleep phase advance (SPA) after total sleep deprivation (TSD)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Total sleep deprivation (TSD)
Number of subjects: 30
Study: 8921561

Group type: EXPERIMENTAL
Intervention: 2-propanol exposure
Number of subjects: 23

Group type: COMPARATOR
Intervention: Room air exposure
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: CSERP measurements
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: General challenge response
Number of subjects: 23
Study: 1748229

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (150 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin + dipyridamole (225 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6847332

Group type: EXPERIMENTAL
Intervention: Counseling plus supportive-expressive psychotherapy
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Counseling plus cognitive-behavioral psychotherapy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Drug counseling alone
Number of subjects: 110
Study: 30205936

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg/day
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 27571390

Group type: EXPERIMENTAL
Intervention: Combined minimal footwear transition and gait-retraining
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gait-retraining only (Control)
Number of subjects: 24
Study: 25822519

Group type: EXPERIMENTAL
Intervention: Auditory, Tactile, Visual, and Vestibular (ATVV) intervention
Number of subjects: 183
Study: 23464577

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin desensitization (100 mg daily)
Number of subjects: 70
Study: 21406089

Group type: EXPERIMENTAL
Intervention: Qualitative investigation of recruitment strategies and trial design changes implemented in Phase II.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes to study information and recruitment strategies implemented in Phase II.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative investigation findings and implemented changes.
Number of subjects: 0
Study: 18976766

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg daily for 12 months)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (no drugs for 12 months)
Number of subjects: 53
Study: 17194546

Group type: EXPERIMENTAL
Intervention: BoNT/A (Botox)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 0.9% saline (NS)
Number of subjects: 18
Study: 15152709

Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy (MDFT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Peer Group Therapy
Number of subjects: 80
Study: 11223729

Group type: EXPERIMENTAL
Intervention: Inhaled methacholine
Number of subjects: 19

Group type: COMPARATOR
Intervention: BHR(+) group (12 patients with bronchial hyperresponsiveness)
Number of subjects: 19
Study: 9326704

Group type: EXPERIMENTAL
Intervention: Vomer flap with a skin graft (VF group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Mucoperiosteal pushback procedure (PB group)
Number of subjects: 12
Study: 7942049

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (400 I.U. d‐1) and ascorbic acid (200 mg d‐1) supplementation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3263876

Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxetine 60-80 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline 100 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline 150-200 mg daily
Number of subjects: 0
Study: 4571680

Group type: EXPERIMENTAL
Intervention: Linoleate supplementation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Oleate mixture
Number of subjects: 75
Study: 31797437

Group type: EXPERIMENTAL
Intervention: Surgical excision, carbon dioxide (CO2) laser therapy, and triamcinolone acetonide (TAC) intralesional injections during surgery and follow-up.
Number of subjects: 21
Study: 29353534

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) challenge
Number of subjects: 35

Group type: COMPARATOR
Intervention: TRP‐balanced control condition (BAL)
Number of subjects: 35
Study: 28637744

Group type: EXPERIMENTAL
Intervention: Group-based care model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 0
Study: 25592133

Group type: EXPERIMENTAL
Intervention: ALN + ELD
Number of subjects: 219

Group type: COMPARATOR
Intervention: ALN + VitD
Number of subjects: 219
Study: 22925277

Group type: EXPERIMENTAL
Intervention: Postpartum sterilisation with titanium clip
Number of subjects: 0

Group type: COMPARATOR
Intervention: Partial salpingectomy
Number of subjects: 0
Study: 21486976

Group type: COMPARATOR
Intervention: IM20 × 3 (standard dose, 20 μg)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: IM40 × 4 (double doses, 40 μg)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: ID4 × 4 (low doses, 4 μg)
Number of subjects: 437
Study: 18392831

Group type: EXPERIMENTAL
Intervention: Ultravist 300 (300 mg iodine/ml) at a flow rate of 4.9 ml/s, 148 ml
Number of subjects: 192

Group type: COMPARATOR
Intervention: Ultravist 370 (370 mg iodine/ml) at a flow rate of 4.0 ml/s, 120 ml
Number of subjects: 192
Study: 16870002

Group type: EXPERIMENTAL
Intervention: High in non‐dairy Ca (calcium citrate) but low in vitamin D (HC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High in dairy Ca and vitamin D (HD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low in dairy Ca and vitamin D (LD; control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All sources of Ca intake
Number of subjects: 8
Study: 12931764

Group type: EXPERIMENTAL
Intervention: Toothbrush A (Sonicare Plus) activated
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Toothbrush B (Braun Oral B) activated
Number of subjects: 0
Study: 10873733

Group type: EXPERIMENTAL
Intervention: Early elective surgery
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Ultrasonography surveillance until aneurysm diameter exceeded 5.5 cm
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Patients without any trace of plasma cotinine
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: FEV(1) levels
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Positive for plasma cotinine
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Without trace of plasma cotinine
Number of subjects: 1090
Study: 9069163

Group type: EXPERIMENTAL
Intervention: Measurement of lumbar bone mineral density and routine biochemical parameters (serum phosphorus, estrone, androstenedione, and urine calcium)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Discriminant functions based on lumbar bone density and biochemical parameters
Number of subjects: 92
Study: 8511445

Group type: COMPARATOR
Intervention: Placebo-controlled vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Log method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Score method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poisson method
Number of subjects: 0
Study: 2980547

Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 0
Study: 29860224

Group type: EXPERIMENTAL
Intervention: Fascia iliaca block (FIB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lumbar plexus block (LPB)
Number of subjects: 50
Study: 27321165

Group type: EXPERIMENTAL
Intervention: LCZ696 (sacubitril/valsartan)
Number of subjects: 26

Group type: COMPARATOR
Intervention: simvastatin
Number of subjects: 26
Study: 24801467

Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 42

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study: 22595386

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (4 g daily for 8 weeks)
Number of subjects: 17
Study: 20517959

Group type: EXPERIMENTAL
Intervention: Everolimus eluting stent (EES)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bare metal stent (control)
Number of subjects: 60
Study: 18035098

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate 160 mg daily for 26 weeks
Number of subjects: 237

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study: 16186437

Group type: COMPARATOR
Intervention: Conventional treatment with aspirin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Conventional treatment plus colchicine 1.0 to 2.0 mg for the first day and then 0.5 to 1.0 mg/d for 3 months
Number of subjects: 120
Study: 12375656

Group type: EXPERIMENTAL
Intervention: Platelets stored for 5 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Platelets stored for 7 days
Number of subjects: 24
Study: 11715489

Group type: EXPERIMENTAL
Intervention: GLN group (glutamine dipeptide enriched enteral nutrition at 0.5 g.kg‐1.day‐1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GLN group
Number of subjects: 24
Study: 8637957

Group type: EXPERIMENTAL
Intervention: Taiwan Aboriginal Acculturation Scale (TAAS)
Number of subjects: 144
Study: 2316233

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide gel (30 mL) with quinidine gluconate (648 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Quinidine gluconate (648 mg) without aluminum hydroxide gel
Number of subjects: 8
Study: 341313

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (0.5 mg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30630371

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Captopril + Vildagliptin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Captopril + Metformin
Number of subjects: 120
Study: 29960288

Group type: EXPERIMENTAL
Intervention: Tiaoshen Kaiqiao acupuncture therapy and placebo starch tablets treatment
Number of subjects: 58

Group type: COMPARATOR
Intervention: Fluoxetine tablets and body acupuncture treatment
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Tiaoshen Kaiqiao acupuncture therapy
Number of subjects: 58
Study: 25466703

Group type: EXPERIMENTAL
Intervention: Nicotine (6‐mg gum) + MAO‐A inhibition (moclobemide 75 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nicotine (6‐mg gum)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 23439759

Group type: EXPERIMENTAL
Intervention: Melatonin 20 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 20981577

Group type: EXPERIMENTAL
Intervention: Looking ≥ 5 years older than actual age
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Looking ≥ 10 years older than actual age
Number of subjects: 126
Study: 18978029

Group type: EXPERIMENTAL
Intervention: Conventional rTMS (0.5 Hz)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Conventional rTMS (10 Hz)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Theta burst stimulation (cTBS)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Theta burst stimulation (iTBS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Motor training (days 1 to 4)
Number of subjects: 22
Study: 17553226

Group type: EXPERIMENTAL
Intervention: MSS‐HTA (multiple site‐specific heteroduplex tracking assay)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard PCR
Number of subjects: 87
Study: 14998784

Group type: EXPERIMENTAL
Intervention: BCAA ingestion during and after resistance exercise
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo ingestion during and after resistance exercise
Number of subjects: 7
Study: 11464450

Group type: EXPERIMENTAL
Intervention: Eprosartan (400-800 mg) alone or in combination with hydrochlorothiazide (HCTZ)
Number of subjects: 706
Study: 9513875

Group type: EXPERIMENTAL
Intervention: Prenate 90
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Stuartnatal Plus
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prenatal 1/1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Natalins Rx
Number of subjects: 100

Group type: COMPARATOR
Intervention: One-A-Day (without iron)
Number of subjects: 100
Study: 7934950

Group type: EXPERIMENTAL
Intervention: Reference-point landmarks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Perspective from which the text was written (route or survey)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Presence of a map at learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Order of information in the text (linear or anchors-first)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amount of information available while drawing sketch maps (full text, landmark names only, or no information)
Number of subjects: 0
Study: 2923641

Group type: EXPERIMENTAL
Intervention: Experimental group - instructed to find and read information relating directly to their patients' conditions
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group - assigned required readings
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 31794342

Group type: EXPERIMENTAL
Intervention: 1.5 mm-C (Filtek Z350 XT)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 1.5 mm-B (Filtek Bulk Fill Posterior)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 3 mm-C (Filtek Z350 XT)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 3 mm-B (Filtek Bulk Fill Posterior)
Number of subjects: 77
Study: 29095245

Group type: EXPERIMENTAL
Intervention: Cooled Radiofrequency Ablation (CRFA)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Intra-articular Steroid (IAS) injection
Number of subjects: 151
Study: 28783858

Group type: EXPERIMENTAL
Intervention: HPV vaccine group (n=48)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo group (n=43)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 91
Study: 26355928

Group type: EXPERIMENTAL
Intervention: Sulodexide (Vessel Due F) treatment for 50 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control Group (no specific intervention mentioned)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Sulodexide (Vessel Due F) treatment
Number of subjects: 62
Study: 23770234

Group type: EXPERIMENTAL
Intervention: Occlusive wrap
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 21128816

Group type: EXPERIMENTAL
Intervention: Metformin (M)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Metformin (M) plus Levothyroxine (L‐T₄)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Levothyroxine (L‐T₄)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 66
Study: 17641893

Group type: EXPERIMENTAL
Intervention: Capecitabine 628 mg/m² b.i.d. plus paclitaxel 80 mg/m²
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Capecitabine 829 mg/m² b.i.d. plus paclitaxel 80 mg/m²
Number of subjects: 9
Study: 15746509

Group type: EXPERIMENTAL
Intervention: Nonpharmacologic therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacologic therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Behavioral therapy
Number of subjects: 0
Study: 12911181

Group type: EXPERIMENTAL
Intervention: High-dose albuterol (HDA)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Circulaire nebulizer (C-Neb)
Number of subjects: 108
Study: 10232855

Group type: EXPERIMENTAL
Intervention: MART (Muscular Awareness Relaxation Training)
Number of subjects: 23

Group type: COMPARATOR
Intervention: TENS (Transcutaneous Electrical Neural Stimulation)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study: 8546472

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (400 mg UFT therapy daily for 10 days)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No preoperative chemotherapy
Number of subjects: 55